STAT3 and cancer: Pimozide has gained attention as an anti-cancer agent by acting as a STAT5 inhibitor in chronic myelogenous leukemia cells [18], as well as an inhibitor of STAT3 signaling pathway in hepatocellular carcinoma and suppressing cancer stem-like cell maintenance [19].